The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)

Immunotherapy has emerged as a promising new treatment modality for head and neck cancer, offering the potential for targeted and effective cancer management. Squamous cell carcinomas pose significant challenges due to their aggressive nature and limited treatment options. Conventional therapies suc...

詳細記述

書誌詳細

主要な著者:	Che-Wei Wang, Pulak Kumar Biswas, Atikul Islam, Mu-Kuan Chen, Pin Ju Chueh
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2024-02-01
シリーズ:	Cells
主題:	immunotherapy immune checkpoint inhibitors head and neck squamous cell carcinoma (HNSCC) oral carcinoma programmed cell death protein 1 programmed death ligand-1 (PD-1/PD-L1)
オンライン･アクセス:	https://www.mdpi.com/2073-4409/13/5/413
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!